Lymphome und Leukämien in bevölkerungsbezogenen Krebsregistern in Deutschland

Federal law enacted in 1995 aims at nation-wide cancer registration, the details of realization based on local regulations being left to the individual Federal states. The impact of different approaches and regulations on the results of registration was investigated at three well-established records in the Saarland, Hamburg and North-Rhine Westphalia, taking the group of lymphoma and leukaemia (ICD 200-208) taken as an example. Material and methods: Incidence and mortality rates calculated by the record files for the period from 1987 to 1994 were compared. The resulting mortality/incidence ratios were compared as well as the percentage of cases in each register with death certificates (DCO) as the only information source. Results: There was a distinct increase of incidence rates visible in Hamburg and Munster. As far as the male patients was concerned, both records attained the level of Saarland at the end of the period. However, the leukaemia and lymphoma mortality figures for males and females was about 10% lower for Saarland than in the comparative regions. The male mortality incidence ratio was 0.55 for Saarland versus 0.60 average in Hamburg and Munster at the end of the period. In Saarland and Hamburg there was a decrease of DCO-cases from 14% to less than 6% in 1994. More constant values around 11% could be observed in the Munster registry. The distribution of diagnosis within the group as well as age-specific incidence rates for the selected diagnosis ,,lymphatic leukaemia (ICD 204) and Hodgkin's disease (ICD 201) yielded only slight differences. Conclusion: The increase of incidence rates in Munster and Hamburg indicates more complete reporting. Assuming that the survival rates are the same in the three regions, the lower mortality in Saarland points to lower morbidity. Hence in spite of a definite approximation the cancer registries in Hamburg and Munster do not reach the level of completeness of the Saarland cancer registry. This may be due to the informed patient consent required by regional law for reports to the registry. To achieve completeness a special reporting procedure for pathological and haematological institutes is mandatory. Simple indicators should be available in each registry for continuous estimation of completeness. Standardised case definitions and rules for the coding of diagnosis in cancer registries will improve national and international comparability and feasibility of data exchange.